Top Markets
Coin of the day
Apollo Endosurgery, Inc. Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc.

APEN
株式のランク #18060
Apollo Endosurgery, Inc. is a medical technology firm specializing in the... Apollo Endosurgery, Inc. is a medical technology firm specializing in the creation, development, and commercialization of advanced medical instruments. Among its products are the OverStitch and OverStitch Sx Endoscopic Suturing Systems, which empower physicians to perform advanced endoscopic procedures by suturing and securing tissue approximation via a flexible endoscope. The company also features the Orbera intragastric balloon system, available under brands such as Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System. This system aids in weight management by decreasing stomach capacity and slowing gastric emptying, thereby encouraging reduced food intake. Additionally, it provides the X-Tack Endoscopic HeliX Tacking System, a suture-based device designed for repairing defects in both the upper and lower gastrointestinal tract. Its medical solutions are distributed to various healthcare providers, including hospitals, outpatient surgical centers, clinics, and individual physicians, across the United States, Australia, Costa Rica, and several European nations. Founded in 2005, Apollo Endosurgery, Inc. maintains its headquarters in Austin, Texas.
株価
$10.00
最終同期: 2023-04-11
時価総額
$214.01M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Apollo Endosurgery, Inc. (APEN)

カテゴリー

Apollo Endosurgery, Inc.(APEN)の利益
2026 時点の利益 TTM: 0
Apollo Endosurgery, Inc. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Apollo Endosurgery, Inc. の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益